Patients Jobs About Novo Nordisk Contact information Finland | Media Research and development Responsible business Do you have type 2 diabetes? We are looking for people with type 2 diabetes for an international clinical trial. Read more and come along 1234 Prev Next Follow us on Facebook What's new in diabetes? What speaks to us today? Like us on Facebook and join the club! Ask about our products and order materials from customer service novoInfo Therapy areas Select the therapy area Diabetes Hemophilia Growth Hormone Menopause Welcome to innovate! We will organize a workshop for diabetics and their relatives on November 14, 2017. Read more and come along. Novo Nordisk Farma Oy - latest releases 05 Jul 2017 Fiasp® ─ new fast-acting insulin aspart for special replacement on July 1, 2017 09 Jun 2017 Most physicians consented to the disclosure of collaborative information 31 May 2017 Read more Important safety information about NovoPen ® Echo ® and NovoPen ® 5 Insulin pens on 5 July 2017 Novo Nordisk will replace the insulin reservoir holder in certain batches in Finland to ensure safe use of the products by patients. Read more The manufacturer of the NovoPen ® Echo ® and NovoPen ® 5 insulin injectors will be replaced on 5 July 2017 . Läs mera We offer 0 job opportunities Search Vacancies in Finland We do not currently have any vacancies. Submit an open application Who are we The Danish company Novo Nordisk is a global pharmaceutical company with more than 90 years of experience as a pioneer in the development of diabetes care. The company is also a leader in the development of hemophilia treatment, growth hormone therapy and menopausal hormone therapy. Novo Nordisk has approximately 41,400 employees (June 2017) in 77 different countries and its products are marketed in more than 165 countries. Novo Nordisk A / S novonordisk.com Or select: other sites Novo Nordisk worldwide Map and addresses Facebook © Novo Nordisk A / S 2017 Disclaimer and Privacy